Dr. Sandrine Sander
© dkfz.de
Sandrine Sander is head of the Max Eder Junior Research Group “Adaptive Immunity and Lymphoma". For her research in the lymphoma field she received doctorates from the University of Ulm (MD and PhD), where she has studied at the Medical School and the International Graduate School for Molecular Medicine (IGradU). Then, she joined Klaus Rajewsky’s group at the Immune Disease Institute at Harvard Medical School in Boston for a postdoctoral fellowship, and she continued her work on modeling human lymphomas in mice in his group at the Max Delbrück Center in Berlin.
In 2015, Sandrine Sander was appointed an independent junior group leader position at the DKFZ/NCT. Her group is supported by a start-up grant in the Max Eder program of the German Cancer Aid, which aims to promote excellent translational research, as well as individual project grants, e.g. by the German José Carreras Leukemia Foundation and the Else Kröner Fresenius Stiftung. B cells and the mechanisms of their malignant transformation are in the focus of ongoing research in Sandrine Sander's lab (for more details please visit the lab homepage). In the context of these projects she could establish a national and international network of collaboration partners who are experts in the field.
Sandrine Sander serves as reviewer for several journals (e.g. Leukemia, Blood, Oncotarget) and she was awarded the Curt Meyer Memorial Prize (Berliner Krebsgesellschaft) and the Franziska Kolb Prize (Franziska Kolb Stiftung).